Fertility Treatment Market 2027 By Drug, Procedure, End User | The Insight Partners

Fertility Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug ( Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment, Gonadotrophins, Aromatase Inhibitors, Estrogen Receptor Modulators, Dopamine Agonists, Metformin Hydrochloride, Others. ); Procedure ( Assisted Reproductive Technology, Artificial Insemination, Hysteroscopy, Laparoscopy And Robotic Laparoscopy, Laparotomy/Open Surgery, Egg Retrieval, Varicocelectomy, Vasectomy Reversal (Vasovasostomy Or Vasoepididymostomy), Sperm Retrieval (Epididymal Aspiration) ); End User ( Fertility Clinics, Hospitals, Clinical Research Institutes, Others )

Report Code: TIPRE00012510 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Fertility treatment refers to treatment options used to stimulate the production of egg or sperm and includes procedures that handle eggs, sperm, or embryos. Fertility drugs are used to treat Ovulation disorders which accounts for 25% of female infertility cases. Fertility drugs stimulate ovulation in females thus promoting fertility. The most common fertility drugs include Clomid, Femara, and gonadotropins. Assisted reproductive technologies (ART) includes fertility treatments that involve Assisted reproductive technologies (ART) refer to fertility treatments that involve the handling of eggs or embryos. GIFT (gamete intrafallopian transfer), ZIFT (zygote intrafallopian transfer) and others.

MARKET DYNAMICS

The fertility treatment market is driving due to the rise in awareness about fertility drugs, development of effective treatments, and rising infertility cases. However, high cost of fertility treatments are expected to hamper the growth of the global fertility treatment market.

MARKET SCOPE

The "Fertility Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of fertility treatment market with detailed market segmentation by drug, procedure and end user. The fertility treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in fertility treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The fertility treatment market is segmented on the basis of drug, procedure and end user. Based on drug, the market is segmented as clomiphene citrate, letrozole, serophene, hormone treatment, gonadotrophins, aromatase inhibitors, estrogen receptor modulators, dopamine agonists, metformin hydrochloride, and others. On the basis of procedure, the market is categorized as assisted reproductive technology, artificial insemination, hysteroscopy, laparoscopy and robotic laparoscopy, laparotomy/open surgery, egg retrieval, varicocelectomy, vasectomy reversal (vasovasostomy or vasoepididymostomy), sperm retrieval (epididymal aspiration). On the basis of end user, the market is categorized as fertility clinics, hospitals, clinical research institutes, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the fertility treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The fertility treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting fertility treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the fertility treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the fertility treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from fertility treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the fertility treatment market.

The report also includes the profiles of key players in fertility treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Merck & Co. Pharmaceutical Company
  •   Noven Pharmaceutical Inc.
  •   Janssen Pharmaceuticals Inc.
  •   Personal Products Company
  •   Pfizer Inc.
  •   Eli Lilly
  •   Baxter Healthcare Corporation
  •   Ferring Pharmaceuticals Inc.
  •   Procter & Gamble Pharmaceuticals
  •   Emd Serono Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS


1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Fertility Treatment Market - By Drug
1.3.2 Fertility Treatment Market - By Procedure
1.3.3 Fertility Treatment Market - By End User
1.3.4 Fertility Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. FERTILITY TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. FERTILITY TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. FERTILITY TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. FERTILITY TREATMENT - GLOBAL MARKET OVERVIEW
6.2. FERTILITY TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. FERTILITY TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG
7.1. OVERVIEW
7.2. DRUG MARKET FORECASTS AND ANALYSIS
7.3. CLOMIPHENE CITRATE
7.3.1. Overview
7.3.2. Clomiphene Citrate Market Forecast and Analysis
7.4. LETROZOLE
7.4.1. Overview
7.4.2. Letrozole Market Forecast and Analysis
7.5. SEROPHENE
7.5.1. Overview
7.5.2. Serophene Market Forecast and Analysis
7.6. HORMONE TREATMENT
7.6.1. Overview
7.6.2. Hormone Treatment Market Forecast and Analysis
7.7. GONADOTROPHINS
7.7.1. Overview
7.7.2. Gonadotrophins Market Forecast and Analysis
7.8. AROMATASE INHIBITORS
7.8.1. Overview
7.8.2. Aromatase Inhibitors Market Forecast and Analysis
7.9. ESTROGEN RECEPTOR MODULATORS
7.9.1. Overview
7.9.2. Estrogen Receptor Modulators Market Forecast and Analysis
7.10. DOPAMINE AGONISTS
7.10.1. Overview
7.10.2. Dopamine Agonists Market Forecast and Analysis
7.11. METFORMIN HYDROCHLORIDE
7.11.1. Overview
7.11.2. Metformin Hydrochloride Market Forecast and Analysis
7.12. OTHERS.
7.12.1. Overview
7.12.2. Others. Market Forecast and Analysis
8. FERTILITY TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - PROCEDURE
8.1. OVERVIEW
8.2. PROCEDURE MARKET FORECASTS AND ANALYSIS
8.3. ASSISTED REPRODUCTIVE TECHNOLOGY
8.3.1. Overview
8.3.2. Assisted Reproductive Technology Market Forecast and Analysis
8.4. ARTIFICIAL INSEMINATION
8.4.1. Overview
8.4.2. Artificial Insemination Market Forecast and Analysis
8.5. HYSTEROSCOPY
8.5.1. Overview
8.5.2. Hysteroscopy Market Forecast and Analysis
8.6. LAPAROSCOPY AND ROBOTIC LAPAROSCOPY
8.6.1. Overview
8.6.2. Laparoscopy And Robotic Laparoscopy Market Forecast and Analysis
8.7. LAPAROTOMY/OPEN SURGERY
8.7.1. Overview
8.7.2. Laparotomy/Open Surgery Market Forecast and Analysis
8.8. EGG RETRIEVAL
8.8.1. Overview
8.8.2. Egg Retrieval Market Forecast and Analysis
8.9. VARICOCELECTOMY
8.9.1. Overview
8.9.2. Varicocelectomy Market Forecast and Analysis
8.10. VASECTOMY REVERSAL (VASOVASOSTOMY OR VASOEPIDIDYMOSTOMY)
8.10.1. Overview
8.10.2. Vasectomy Reversal (Vasovasostomy Or Vasoepididymostomy) Market Forecast and Analysis
8.11. SPERM RETRIEVAL (EPIDIDYMAL ASPIRATION)
8.11.1. Overview
8.11.2. Sperm Retrieval (Epididymal Aspiration) Market Forecast and Analysis
9. FERTILITY TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. FERTILITY CLINICS
9.3.1. Overview
9.3.2. Fertility Clinics Market Forecast and Analysis
9.4. HOSPITALS
9.4.1. Overview
9.4.2. Hospitals Market Forecast and Analysis
9.5. CLINICAL RESEARCH INSTITUTES
9.5.1. Overview
9.5.2. Clinical Research Institutes Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. FERTILITY TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Fertility Treatment Market Overview
10.1.2 North America Fertility Treatment Market Forecasts and Analysis
10.1.3 North America Fertility Treatment Market Forecasts and Analysis - By Drug
10.1.4 North America Fertility Treatment Market Forecasts and Analysis - By Procedure
10.1.5 North America Fertility Treatment Market Forecasts and Analysis - By End User
10.1.6 North America Fertility Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Fertility Treatment Market
10.1.6.1.1 United States Fertility Treatment Market by Drug
10.1.6.1.2 United States Fertility Treatment Market by Procedure
10.1.6.1.3 United States Fertility Treatment Market by End User
10.1.6.2 Canada Fertility Treatment Market
10.1.6.2.1 Canada Fertility Treatment Market by Drug
10.1.6.2.2 Canada Fertility Treatment Market by Procedure
10.1.6.2.3 Canada Fertility Treatment Market by End User
10.1.6.3 Mexico Fertility Treatment Market
10.1.6.3.1 Mexico Fertility Treatment Market by Drug
10.1.6.3.2 Mexico Fertility Treatment Market by Procedure
10.1.6.3.3 Mexico Fertility Treatment Market by End User
10.2. EUROPE
10.2.1 Europe Fertility Treatment Market Overview
10.2.2 Europe Fertility Treatment Market Forecasts and Analysis
10.2.3 Europe Fertility Treatment Market Forecasts and Analysis - By Drug
10.2.4 Europe Fertility Treatment Market Forecasts and Analysis - By Procedure
10.2.5 Europe Fertility Treatment Market Forecasts and Analysis - By End User
10.2.6 Europe Fertility Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Fertility Treatment Market
10.2.6.1.1 Germany Fertility Treatment Market by Drug
10.2.6.1.2 Germany Fertility Treatment Market by Procedure
10.2.6.1.3 Germany Fertility Treatment Market by End User
10.2.6.2 France Fertility Treatment Market
10.2.6.2.1 France Fertility Treatment Market by Drug
10.2.6.2.2 France Fertility Treatment Market by Procedure
10.2.6.2.3 France Fertility Treatment Market by End User
10.2.6.3 Italy Fertility Treatment Market
10.2.6.3.1 Italy Fertility Treatment Market by Drug
10.2.6.3.2 Italy Fertility Treatment Market by Procedure
10.2.6.3.3 Italy Fertility Treatment Market by End User
10.2.6.4 Spain Fertility Treatment Market
10.2.6.4.1 Spain Fertility Treatment Market by Drug
10.2.6.4.2 Spain Fertility Treatment Market by Procedure
10.2.6.4.3 Spain Fertility Treatment Market by End User
10.2.6.5 United Kingdom Fertility Treatment Market
10.2.6.5.1 United Kingdom Fertility Treatment Market by Drug
10.2.6.5.2 United Kingdom Fertility Treatment Market by Procedure
10.2.6.5.3 United Kingdom Fertility Treatment Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Fertility Treatment Market Overview
10.3.2 Asia-Pacific Fertility Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Fertility Treatment Market Forecasts and Analysis - By Drug
10.3.4 Asia-Pacific Fertility Treatment Market Forecasts and Analysis - By Procedure
10.3.5 Asia-Pacific Fertility Treatment Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Fertility Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Fertility Treatment Market
10.3.6.1.1 Australia Fertility Treatment Market by Drug
10.3.6.1.2 Australia Fertility Treatment Market by Procedure
10.3.6.1.3 Australia Fertility Treatment Market by End User
10.3.6.2 China Fertility Treatment Market
10.3.6.2.1 China Fertility Treatment Market by Drug
10.3.6.2.2 China Fertility Treatment Market by Procedure
10.3.6.2.3 China Fertility Treatment Market by End User
10.3.6.3 India Fertility Treatment Market
10.3.6.3.1 India Fertility Treatment Market by Drug
10.3.6.3.2 India Fertility Treatment Market by Procedure
10.3.6.3.3 India Fertility Treatment Market by End User
10.3.6.4 Japan Fertility Treatment Market
10.3.6.4.1 Japan Fertility Treatment Market by Drug
10.3.6.4.2 Japan Fertility Treatment Market by Procedure
10.3.6.4.3 Japan Fertility Treatment Market by End User
10.3.6.5 South Korea Fertility Treatment Market
10.3.6.5.1 South Korea Fertility Treatment Market by Drug
10.3.6.5.2 South Korea Fertility Treatment Market by Procedure
10.3.6.5.3 South Korea Fertility Treatment Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Fertility Treatment Market Overview
10.4.2 Middle East and Africa Fertility Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Fertility Treatment Market Forecasts and Analysis - By Drug
10.4.4 Middle East and Africa Fertility Treatment Market Forecasts and Analysis - By Procedure
10.4.5 Middle East and Africa Fertility Treatment Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Fertility Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Fertility Treatment Market
10.4.6.1.1 South Africa Fertility Treatment Market by Drug
10.4.6.1.2 South Africa Fertility Treatment Market by Procedure
10.4.6.1.3 South Africa Fertility Treatment Market by End User
10.4.6.2 Saudi Arabia Fertility Treatment Market
10.4.6.2.1 Saudi Arabia Fertility Treatment Market by Drug
10.4.6.2.2 Saudi Arabia Fertility Treatment Market by Procedure
10.4.6.2.3 Saudi Arabia Fertility Treatment Market by End User
10.4.6.3 U.A.E Fertility Treatment Market
10.4.6.3.1 U.A.E Fertility Treatment Market by Drug
10.4.6.3.2 U.A.E Fertility Treatment Market by Procedure
10.4.6.3.3 U.A.E Fertility Treatment Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Fertility Treatment Market Overview
10.5.2 South and Central America Fertility Treatment Market Forecasts and Analysis
10.5.3 South and Central America Fertility Treatment Market Forecasts and Analysis - By Drug
10.5.4 South and Central America Fertility Treatment Market Forecasts and Analysis - By Procedure
10.5.5 South and Central America Fertility Treatment Market Forecasts and Analysis - By End User
10.5.6 South and Central America Fertility Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Fertility Treatment Market
10.5.6.1.1 Brazil Fertility Treatment Market by Drug
10.5.6.1.2 Brazil Fertility Treatment Market by Procedure
10.5.6.1.3 Brazil Fertility Treatment Market by End User
10.5.6.2 Argentina Fertility Treatment Market
10.5.6.2.1 Argentina Fertility Treatment Market by Drug
10.5.6.2.2 Argentina Fertility Treatment Market by Procedure
10.5.6.2.3 Argentina Fertility Treatment Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL FERTILITY TREATMENT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. FERTILITY TREATMENT MARKET, KEY COMPANY PROFILES
13.1. MERCK AND CO. PHARMACEUTICAL COMPANY
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. NOVEN PHARMACEUTICALS INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. JANSSEN PHARMACEUTICALS INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. PERSONAL PRODUCTS COMPANY
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. PFIZER INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ELI LILLY
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BAXTER HEALTHCARE CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. FERRING PHARMACEUTICALS INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PROCTER AND GAMBLE PHARMACEUTICALS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. EMD SERONO INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Merck & Co. Pharmaceutical Company
2. Noven Pharmaceutical Inc.
3. Janssen Pharmaceuticals Inc.
4. Personal Products Company
5. Pfizer Inc.
6. Eli Lilly
7. Baxter Healthcare Corporation
8. Ferring Pharmaceuticals Inc.
9. Procter & Gamble Pharmaceuticals
10. Emd Serono Inc.
TIPRE00012510
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking